Citigroup Downgrades Kate Spade & Company (KATE)'s stock to Neutral with no specific Price Target. The company offers apparel, handbags, briefcases, travel bags, small leather goods, tabletop products, legwear, bedding, stationery, jewelry, apparel, footwear, optics, fragrances, electronics cases, fashion accessories, beauty, and home décor products.
These analysts also forecasted Growth Estimates for the Current Quarter for KATE to be 27.3%. The 52-week range of the share price is from $3.44 - $8.41. SunTrust Banks, Inc. increased their target price on shares of Kate Spade & Co from $15.00 to $18.00 and gave the company a neutral rating in a research report on Friday, December 30th. Mizuho restated a buy rating and issued a $21.00 price target on shares of Kate Spade & Co in a research note on Wednesday, December 28th.
Kate Spade & Company's RSI is 23.09.
Kate Spade & Company (KATE) will report its next earnings on May 18 BMO. Analysts have a mean recommendation of 2.20 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). The company now has an average rating of Hold and a consensus target price of $22.60.
Top Gainers of the Day: Gilead Sciences, Inc. (NASDAQ:GILD) from Biotechnology
Renaissance Technologies LLC increased its stake in shares of Gilead Sciences by 170.9% in the fourth quarter. Among 9 analysts covering Foundation Medicine ( NASDAQ:FMI ), 0 have Buy rating, 0 Sell and 9 Hold.
Kate Spade & Co (NYSE:KATE), after opening at $17.32, closed at $17.50 by scoring 1.98%. The company is set at a mean analysts' recommendation of 2.40.
The stock's price switched up -16.20% 20-Days Simple Moving Average, dropped -21.54% from 50-Days Simple Moving Average and fell -9.18% from 200 Days Simple Moving Average. The total market capitalization remained at $46.41 billion. For trailing twelve months, EPS value for the stock is $-0.38. The firm had revenue of $271 million for the quarter, compared to the consensus estimate of $299.08 million. The business's revenue for the quarter was down 1.1% compared to the same quarter previous year. The company's institutional ownership is monitored at 0 percent. On average, analysts predict that Kate Spade & Co will post $0.80 earnings per share for the current fiscal year. Zacks Investment Research downgraded Kate Spade & Co from a "buy" rating to a "hold" rating in a report on Tuesday, April 11th. If you are accessing this article on another domain, it was illegally copied and republished in violation of worldwide trademark & copyright law. The original version of this piece can be viewed at https://transcriptdaily.com/2017/04/25/kate-spade-co-kate-lowered-to-strong-sell-at-zacks-investment-research.html.
Hedge funds and other institutional investors have recently modified their holdings of the stock. The short ratio in the company's stock is documented at 1.87 and the short float is around of 6.08%. Profund Advisors LLC boosted its position in shares of Kate Spade & Co by 3.4% in the first quarter. The stock's quarterly performance indicates a Negative momentum of -6.74 percent, whereas its last one month trend is Pessimistic with -25.23 percent. BlackRock Advisors LLC raised its stake in Kate Spade & Co by 2.1% in the third quarter. Finally, Parametrica Management Ltd bought a new position in shares of Kate Spade & Co during the first quarter worth about $210,000. Growth in EPS is an important measure of management performance because it shows how much money the company is making for it's shareholders, not only due to changes in profit, but also after all the effects of issuance of new shares (this is especially important when the growth comes as a result of acquisition).
Kate Spade & Company (KATE) is now showing its ROA (Return on Assets) of 14.9%.
Comments